Stock On High Alert

Unraveling the Cybersecurity Frontier in Space These days, keeping our tech safe isn't just about stopping your phone from getting hacked or your laptop from being bombarded with spam. We're talking bigger, and I mean cosmos-level bigger. The space cybersecurity scene is ramping up, projected to balloon from $5.52 billion in 2026 to a whopping $8.59 billion by 2031....

A Spotlight on Community Finance Leadership Opportunity Finance Network's annual conference, OFN42, was an event that shined brighter than your typical finance summit. Down in New Orleans, this gathering of community development financial institutions (CDFIs) proved that awards season isn’t just for Hollywood elite. At this meet-up, it’s all about who's not only...

A Tech Leap for Muskingum University Muskingum University's digital upgrade with Ellucian Student has finally arrived. It's like trading in your old clunker for a sleek, AI-powered supercar. They’ve moved their core student system to a SaaS-native environment, building on a partnership spanning nearly four decades with Ellucian. This leap isn't just about keeping up...

New Faces, Fresh Perspectives at BRG BRG Communications is upping the ante, folks. As they toast to their 25th year in the biz, this healthcare PR outfit isn't just resting on its laurels. Nope, four big guns just joined their ranks — Caitlin Chase, Leanne Stone, Brandon Kenah, and Vijaya Singh. These additions aren't just for show; they bring a heap of expertise that...

Padel Serves Up in Vegas: A Sporting Spectacle When you stumble onto something like padel popping up on the Las Vegas Strip, it raises eyebrows quicker than an unexpected blackjack win. This sport's charging full throttle into the big leagues, and now it's got MGM Resorts International backing it up. November 18 to 21 is when the rackets will be swinging at Dolby Live at...

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

Mendocino Farms Lands in Legal Hot Water Jobs pay the bills and keep the gears turning. But when a company like Mendocino Farms allegedly chucks out the rulebook, things get messy fast. We're talking about a hefty lawsuit aimed at this chain, accusing them of playing fast and loose with California's labor laws. If you've been around the block like me, you know that...

Primis Financial's Remarkable Quarter Alright, let's talk about Primis Financial Corp. and their Q3 2026 results. Earnings and other financial marks have seen quite the improvement. We're talking profits here that went from $6.8 million in the prior year to $8.7 million this time around. Nothing to sneeze at. Their net income per share climbed up to $0.35 from $0.28,...

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Palantir Technologies Soars with Inclusion in the S&P 500 Palantir Technologies (NYSE: PLTR) has recently seen an impressive rise in its stock prices, thanks to its inclusion in the esteemed S&P 500 index. This news sparked excitement during premarket trading, where shares jumped by over 8%. The S&P Dow Jones Indices confirmed that Palantir will officially join the index,...

Recent Advances in GSK's Nucala for COPD GSK's phase III trial of its prominent drug Nucala (mepolizumab), aimed at treating chronic obstructive pulmonary disease (COPD), has successfully achieved its primary objective. This notable milestone in COPD treatment represents a significant step forward in therapies for respiratory conditions. The groundbreaking MATINEE study...

Understanding the Legal Landscape for Five9 Investors Faruqi & Faruqi, LLP is reaching out to investors affected by potential losses related to Five9, Inc. To ensure that victims of these circumstances are informed of their legal options, the firm's Securities Litigation Partner, James (Josh) Wilson, is available for direct consultation. He urges anyone who has purchased...

Game Changer for Quantum Technology If you thought the quantum sector was crawling, buckle up. Monarch Quantum, Inc. just landed a huge gig—delivering its integrated Quantum Light Engines™ for NASA’s upcoming Quantum Gravity Gradiometer Pathfinder mission. That’s not just a feather in their cap; it’s a serious validation of their tech chops. This isn’t just...

Jim Pazzanese Appointed to Enhance Global Procurement Strategies Buyers Edge Platform (BEP), a leader in procurement, analytics, and contract management solutions dedicated to the foodservice industry, is excited to welcome Jim Pazzanese as their new Executive Vice President of Global Strategic Procurement. With a robust background spanning over 30 years in foodservice...